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Abstract
Background: Spalax (blind subterranean mole rat), is a mammal adapted to live in fluctuating oxygen levels, and can survive
severe hypoxia and hypercapnia. The adaptive evolution of Spalax to underground life resulted in structural and molecular-
genetic differences comparing to above-ground mammals. These differences include higher myocardial maximal oxygen
consumption, increased lung diffusion capacity, increased blood vessels density, and unique expression patterns of cancer
and angiogenesis related genes such as heparanase, vascular endothelial growth factor, and P53.
Methodology/Principal Findings: Here we elucidate the main characteristics of Spalax lipid profile, as well as its main
antioxidant and serum parameters. Compared to human, Spalax possesses lower total-cholesterol, low density lipoproteins
(LDL) and triglycerides levels, and higher levels of high density lipoproteins (HDL). Apolipoprotein A-I and apolipoprotein B-
100 were significantly lower in Spalax compared to human. Paraoxonase (PON) 1 arylesterase activity, was higher in Spalax
compared to both human and mouse serum levels. Analysis of serum chemistry of Spalax revealed special features in this
mammal.
Conclusions/Significance: Spalax possesses a unique lipid profile with high HDL and low LDL lipoproteins. The antioxidant
serum content in the mole rat is higher than that of human and mouse. Serum C reactive protein (CRP) levels are
significantly lower in Spalax compared to that of human or mouse, reflecting low levels of inflammation. These differences
between Spalax, human and mouse are due to several factors including the intensive activity life-style that Spalax pursue
underground, dietary components, and evolutionary genetic adaptations. Unfolding the genetic basis of these differences
will probably result in unique treatments for a variety of human diseases such as dyslipedemias, inflammation and cancer.
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Introduction
The subterranean blind mole rat of the genus Spalax in Israel
belongs to the mammalian superspecies Spalax ehrenbergi and the
family Spalacidae [1,2]. Spalax lives all its life, averaging three
years, in sealed underground tunnels [2]. The oxygen and carbon
dioxide levels inside the underground Spalax habitat fluctuate
from values similar to those detected above ground to severe
hypoxia and hypercapnia [3]. In laboratory conditions, Spalax
survives oxygen levels as low as 2–3% for several hours, in
contrast to above ground rats that die after less than 3 hours of
exposure to such circumstances [4]. Several mechanisms account
for the increased tolerance of Spalax to hypoxia. These
mechanisms include higher myocardial maximal oxygen con-
sumption [5], decreased diffusion distance of oxygen to the
mitochondria [6], increase in the lung diffusion capacity [6], and
specific differences in myoglobin which augment oxygen delivery
at low oxygen tensions [7]. Blood vessels density in Spalax muscles
is significantly higher than that of rat [8–10]. Vascular
endothelial growth factor [9,10], hypoxia inducible factor [11],
and heparanase (an angiogenesis related enzyme) [12,13] are
constitutively high in some Spalax tissues [9–11]. Unique splice
variants of heparanase were found in some Spalax tissues [12,13].
P53 gene in healthy Spalax individuals possesses amino acid
substitutions in its DNA binding domain identical to mutations
found in human tumors [14,15]. These adaptive substitutions
endow Spalax p53 with several-fold higher activation of cell arrest
and DNA repair genes compared to human p53, and favor
activation of DNA repair genes over apoptotic genes [14,15].
Specific features of other molecules such as hemoglobin,
haptoglobin, neuroglobin and cytoglobin were described in Spalax
as well [1,2].
Spalax daily life involves strenuous physical activity [1,2].
Spalax digs to search for food (primarily subterranean plant
organs such as roots, corms, bulbs), maintain its underground
constructions, and search for mating partners [1,2]. This
probably explains the highly developed muscle mass that this
mammal possesses. All the above characteristics of Spalax led us
to investigate its lipid profile, serum oxidation parameters, and
serum chemistry.
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Spalax lipid profile
Lipid profile was measured in serum samples obtained from 3
mole rat (Spalax judaei) females, captured in the field in the day of
the experiment. Spalax lipid profile was compared to those of
mouse and human. Mole rat total cholesterol (mean6SD) was
16468 mg/dl, compared to 8065 mg/dl in mouse (p,0.0001)
and 212627 mg/dl in human (p,0.05) (Figure 1A). High density
lipoprotein of mole rat was 113610 mg/dl, versus 6869 mg/dl in
mouse (p,0.004) and 4268 mg/dl in human (p,0.0006)
(Figure 1B). Low density lipoprotein of mole rat was 3165 mg/
dl, compared to 1767 mg/dl in mouse (p,0.04) and
111611 mg/dl in human (p,0.0004) (Figure 1C). The average
serum triglycerides level of mole rat was 4464 mg/dl, compared
to 65613 mg/dl in mouse (p=0.06) and 94612 mg/dl in human
(p,0.003) (Figure 1D). Apolipoprotein A-I and Apolipoprotein B-
100 were also determined in serum of mole rat, mouse, and
human. Mole rat Apolipoprotein A-I was 3562 mg/dl, while its
level in mouse was 9667 mg/dl (p,0.0002), and in human
119617 mg/dl (p,0.002) (Figure 2A). Apolipoprotein B-100 of
mole rat was 1363 mg/dl, compared to 2164 mg/dl in mouse
(p,0.053), and 86613 mg/dl in human (p,0.0007) (Figure 2B).
Mole rat (Spalax) serum oxidation
Serum AAPH-induced oxidation of Spalax was 2767 (nmole
TBARS/ml) compared to 1362 (nmole TBARS/ml) in mouse
(p,0.03), and 4563 (nmole TBARS/ml) in human (p,0.02)
(Figure 3A). Paraoxonase (PON) 1 arylesterase (an enzyme present
on the HDL liporopotein that possesses antioxidants properties)
level in mole rat serum was 375635 (U/ml), while its level in
mouse was 269636 (U/ml) (p,0.03), and in human 182621 (U/
ml) (p,0.0015) (Figure 3B). C reactive protein (CRP), an acute
phase protein produced by the liver and by adipocytes, was
prominently lower in mole rat (0.1860.06 (mg/L)) than in mouse
(3.0360.65 (mg/L)) and human (4.6760.65 (mg/L)) (p val-
ues,0.002 and ,0.0003 respectively) (Figure 3C).
Spalax serum chemistry
Spalax serum chemistry was determined from three mole rat
females, which appeared to be pregnant. Mole rat serum
chemistry was compared to that of human (Table 1). In most
parameters the differences between mole rat and human proved
statistically significant. Of special interest are the higher magne-
sium, phosphorus, and amylase levels in Spalax. High glucose levels
detected in mole rats may be due to the fact that the measurement
was not performed after 12 hours fasting as in humans. High
alkaline phosphatase levels of Spalax may be due to pregnancies
that were detected in the study individuals.
Discussion
Spalax adaptation to underground life
Spalax is a mammal that is adapted to tolerate severe hypoxia
[1–11]. Spalax evolutionary ancestors went underground due to
Figure 1. Comparison of mole rat (Spalax), mouse and human lipid profiles. A. Total cholesterol levels (mg/dl). B. High Density Lipoprotein
cholesterol (HDL) levels (mg/dl). C. Low Density Lipoprotein cholesterol (LDL) levels (mg/dl). D. Triglycerides levels (mg/dl). Each bar represents a
mean of three measurements from different individuals. Error bars represents standard deviations.
doi:10.1371/journal.pone.0004528.g001
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change in Spalax living habitat was associated with several
advantages and disadvantages, which elicited evolutionary,
structural and genetic adaptations [1,2]. Among the advantages
that Spalax gained from residing in underground tunnels was
protection from above ground predators, a relatively constant
temperature and humidity, and access to underground food stores
(plant roots) without many competitors. The ‘‘price’’ that Spalax
paid for it was high: it encountered darkness, hypoxia, hypercap-
nia, complex energetics, poor food, and high pathogenicity it had
to adaptively combat. The underground tunnels’ oxygen and
carbon dioxide content fluctuate dramatically, especially in rainy
weather, when water fills a large volume of the Spalax burrows [3].
Spalax structural adaptations to the underground environment
resulted in regression in some organs and progression of others [1].
Among the organs that regressed during Spalax evolution: I) the
eyes which turned to be atrophic and subcutaneous. Actually,
Spalax is unable to see, but still can discriminate between light and
darkness i.e. it exercises photoperiodic perception, and maintain a
circadian rhythm cycle [16]; II) Spalax limbs have been reduced in
Figure 2. Comparison of mole rat (Spalax), mouse and human serum apolipoprotein A-I and apolipoprotein B-100. A. Apolipoprotein
A-I was measured in mole rat (Spalax) (n=3), mouse (n=3), and human (n=3). Apolipoprotein A-I of mole rat was 3562 mg/dl, of mouse 9667 mg/
dl, and of human 119617 mg/dl (mean6SD). B. Apolipoprotein B-100 of mole rat was 1363 mg/dl, compared to 2164 mg/dl of mouse, and
86613 mg/dl of human. Bars represent mean values, and error bars represents standard deviations.
doi:10.1371/journal.pone.0004528.g002
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which disappeared to probably allow easier movement [1,2].
Other organs of Spalax progressed as part of the evolutionary
process. These include the muscles, both heart and skeletal
muscles, which hypertrophied in order to sustain the tremendous
efforts that Spalax exerts; the teeth which turned to be big and
strong allowing Spalax to burrow its way through underground
rocks and heavy soil [1,2]; and the brain of Spalax which is
significantly larger than that of rats, probably assisting it in
managing through the extremely stressful life underground [1,2].
Figure 3. Comparison of mole rat (Spalax), mouse and human serum AAPH-induced oxidation and PON1 arylesterase. A. AAPH-
induced oxidation of Spalax was 2767 (nmole TBARS/ml) compared to 1362 (nmole TBARS/ml) in mouse, and 4563 (nmole TBARS/ml) in human. B.
PON1 arylesterase of mole rat was 375635 (U/ml), while its level in mouse was 269636 (U/ml), and in human 182621 (U/ml). C. C reactive protein
(CRP) of mole rat was 0.1860.06 (mg/L), of mouse 3.0360.65 (mg/L), and of human 4.6760.65 (mg/L). Bars represent mean values, and error bars
represents standard deviations.
doi:10.1371/journal.pone.0004528.g003
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Spalax lipid profile shows that this mammal has low total
cholesterol and low density lipoprotein (LDL) on the one hand
and high levels of high density lipoproteins (HDL) on the other
hand (Figure 1). Similar results were found in mouse compared to
human, but HDL levels of Spalax were higher than in mouse
(Figure 1B). The explanation for this unique lipid profile of Spalax
may be due to the strenuous activity that Spalax peruses in its
daily life [1,2]. This activity may demand degradation of lipids
which is mirrored as high serum HDL. The high HDL level
culminates in low LDL levels, as LDL is calculated by decreasing
the amount of HDL from total cholesterol together with 20% of
the triglyceride levels [17]. Other factors that may contribute to
this special lipid profile may be the unique diet that Spalax
consumes, which is composed mainly from plant roots and
geophytes. Changes in diet of human [18], and animal models
[19] were associated with changes in their lipid profiles; further
studies are necessary to elucidate possible positive characteristics
of the diet of this unique mammal. Genetic evolution of Spalax
may be one of the key factors that shape this lipid profile.
Differences of about 15% were found in a variety of Spalax genes
compared to human and other rodents [11–13]. Moreover,
unique splice variants were found in some genes of Spalax that
were not described yet in other mammals [12,13]. Cloning the
genes related to lipid metabolism will elucidate possible special
characteristics that may contribute to this lipid phenotype of
Spalax. Sequencing and analysis of the Spalax genome will help to
unravel the nature of the genetic adaption to hypoxia. Further
studies focusing on lipid profiles of other subterranean mammals
(e.g. naked mole rat [20,21,22], pocket gopher [23], and golden
mole [24]) will allow broader comparison with Spalax lipid profile,
and probably elucidate the evolutionary processes behind its
features.
Spalax serum oxidation
The mole rat serum exhibits features of a low oxidative stress
status, compared to human and mouse. Moreover, the antioxidant
serum content measured in the mole rat was higher than that of
human and mouse. These results could be related to the adaptive
evolution of this mammal to underground stresses, especially to
hypoxia and darkness. Interestingly, high oxidative damage levels
were reported in the longest-living rodent, the naked mole-rat
[21,22], as opposed to Spalax. The CRP serum level which reflects
the inflammatory status of the animal is especially lower in Spalax
compared to that of human and mouse. These results of Spalax
serum come in accordance with previous study that found low
oxidative status in Spalax harderean gland [25]. This very low
baseline of oxidative stress and inflammatory burden could be of
interest to study the early stages of development of atherosclerosis,
which is triggered by both increasing oxidative stress and
inflammation.
Spalax serum chemistry
Our current study elucidates special characteristics of Spalax
serum. Higher magnesium, phosphorus, glucose, and amylase
levels were detected in Spalax compared to human. The higher
serum glucose level in Spalax may be partly due to non-fasting
measurements or due to the pregnancies found in part of the study
individuals. Further studies focusing on measuring fasting glucose
will elucidate this point. Serum amylase was very high in Spalax
(Table 1). The source of this enzyme in Spalax may be pancreatic
or salivary. Serum magnesium and phosphoros were also high in
Spalax compared to human.
Spalax as a model organism for the study of hypoxia and
dyslipidemias
This study defines the Spalax lipid profile, and its serum
oxidative and biochemical properties. These results show that
Spalax serum profile is different not just from that of human, but
from mouse as well. Spalax is an HDL animal with high HDL
cholesterol and low LDL serum levels. Further studies focusing on
the evolutionary mechanisms that led to these differences are
undergoing. We hope that understanding the Spalax genetic
adaptation to hypoxia will help us to utilize similar mechanisms in
managing human diseases related to hypoxia and elucidate ways to
decrease LDL and increase HDL cholesterol in human.
Materials and Methods
Animals
Mole rats. The animals used for Spalax lipid profile and
serum chemistry studies belong to the species Spalax judaei from
the Anza population in northern Samaria Mountains [2]. All the
animals were captured in the field in the same day of the
experiment. Capturing the animals was performed by exposing
the tunnels and trapping the animals while trying to fix the
destroyed construction. The animals used for this study were
female adults and ranged in weight from 80–150 g. The ethics
committee of the University of Haifa approved this experiment.
Mouse. All Mice used in this study were C57Bl mice. The
experimental protocol was approved by the Animal Care and Use
Committee of the Technion.
Humans
Blood was obtained from healthy human volunteers (n=3),
nonsmokers and under no medication. The study was approved by
the Helsinki Committee of the Rambam Medical Center, Israel
Table 1. Comparison of Spalax (mole rat) and human serum
chemistries.
Spalax Human P value
Mean6SD Mean6SD
BUN (mg/dl) 38651 6 63 ,0.003
Glucose (mg/dl) 155631 8566 ,0.02
Calcium (mg/dl) 11619 . 3 60.4 =0.053
Creatinine (mg/dl) 0.2760.06 0.8460.05 ,0.0003
Phosphors (mg/dl) 8.760.2 3.460.3 ,0.0001
GGT (U/l) 11.6662.51 3364 ,0.001
Magnesium (mg/dl) 6.0060.2 1.760.2 ,0.0001
ALP (U/l) 922660 8469 ,0.0001
LDH (U/l) 236626 14668 ,0.005
Amylase (U/l) 14426102 129619 ,0.0001
Sodium (mmol/l) 152631 3 7 62 ,0.002
Chloride (mmol/l) 119631 0 6 63 ,0.006
Total Protein (g/dl) 8.160.6 7.160.3 ,0.05
Albumin (g/dl) 2.660.2 4.660.3 ,0.0006
Uric Acid (mg/L) 0.660.1 6.160.6 ,0.0001
BUN=Blood Urea Nitrogen; GGT=Gamma-Glutamyl Transpeptidase;
ALP=Alkaline Phosphatase; LDH=Lactate Dehydrogenase.
doi:10.1371/journal.pone.0004528.t001
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before the blood donation.
Blood Sampling
Blood samples were obtained from three individuals of each
species (Spalax judaei, Mus domesticus, and Homo sapiens). For blood
sampling from mole rat and mouse, animals were deeply
anesthetized by intramuscular injection of Ketaset CIII (Fort
Dodge, IA) at 5 mg/kg of body weight. Blood was collected
directly from the heart. About 1 ml of blood was sampled from
each animal, which was sacrificed immediately thereafter. Blood
was pooled in separate Eppendorf tubes, centrifuged (14000 RMP,
4uC, 15 minutes), and serum collected in clean tubes. Serum was
analyzed as described below. Sampling of blood from healthy
human volunteers was performed through peripheral venous
punctures, after 12 hours of fast.
Serum Lipid profile determination
Serum lipid profile was assessed by commercial kits, specific for
each analytes, using a diagnostic analyzer (Dimension RXL,
Siemens, Germany). Total cholesterol, total triglycerides and HDL
levels were measured, whereas LDL levels were calculated using
the Friedewald equation. [17]
Serum oxidation parameters
Plasma lipid peroxidation. Serum was incubated in the
absence or presence of 100 mmol/L of the free radical generator 2,
29-azobis-2-amidinopropane hydrochloride (AAPH; Wako
Chemical Industries Ltd, Osaka, Japan) for 2 h at 37uC. AAPH is
a water-soluble azo compound that thermally decomposes to
produce peroxyl radicals at a constant rate. Plasma lipid
peroxidation was determined by measuring the amount generated
of thiobarbituric acid–reactive substances (TBARS) [26].
Serum paraoxonase (arylesterase activity). Arylesterase
activity was measured by using phenylacetate as the substrate.
Initial rates of hydrolysis were determined spectrophotometrically
at 270 nm. The assay mixture included 5 mL serum, 1.0 mmol
phenylacetate/L, and 0.9 mmol CaCl2/L in 20 mmol tris-HCl/L,
pH 8.0. Nonenzymatic hydrolysis of phenylacetate was subtracted
from the total rate of hydrolysis. The extinction coefficient at
270 nm (E270) for the reaction was 1310 (mol/L)
21?cm
21. One
unit of arylesterase activity is equal to 1 mmol phenylacetate
hydrolyzed?min
21?L
21 [27].
Serum chemistry
Serum samples were analyzed for general biochemical param-
eters, such as glucose, electrolytes (sodium, chloride), minerals
(calcium, phosphor, magnesium), liver function markers (alkaline
phosphatase (ALP), c-glutamyl transpeptidase (GGT), lactate
dehydrogenase (LDH)), pancreas function marker (amylase) and
kidneys function markers (blood urea nitrogen (BUN), creatinine,
total protein, albumin, uric acid). In addition, we have determined
the serum levels of C-reactive protein, an acute phase protein
released during inflammatory processes. All parameters were
analyzed by commercial kits, specific for each analytes, using a
diagnostic analyzer (Dimension RXL, Siemens, Germany).
Statistical analysis
All measured serum parameters were determined from at least
three different individuals of each species. Results are reported as
mean6SD. Statistical analysis was performed using student T test.
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